MetaADEDB 2.0 @ LMMD
Visicol
(CMSRRRBRAARQFN-UHFFFAOYSA-N)
Structure
SMILES
OP(=O)(O)O.CCCCCCCCCCCCCCCCC1CO1.O.[Na]
Molecular Formula:
C18H41NaO6P
Molecular Weight:
407.478
Log P:
5.2637
Hydrogen Bond Acceptor:
6
Hydrogen Bond Donor:
4
TPSA:
109.33
CAS Number(s):
N/A
Synonym(s)
1.
Visicol
External Link(s)
PubChem Compound24848124
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AstheniaFAERS: 7US FAERS
2Electrolyte imbalanceFAERS: 7US FAERS
3VomitingFAERS: 7US FAERS
4Foreign body traumaFAERS: 4US FAERS
5MalaiseFAERS: 4US FAERS
6NauseaFAERS: 4US FAERS
7Blood potassium decreasedFAERS: 3US FAERS
8DizzinessFAERS: 3US FAERS
9Feeling abnormalFAERS: 3US FAERS
10AmnesiaFAERS: 2US FAERS
11Atrial FibrillationFAERS: 2US FAERS
12Blood sodium decreasedFAERS: 2US FAERS
13Cerebral InfarctionFAERS: 2US FAERS
14CyanosisFAERS: 2US FAERS
15DroolingFAERS: 2US FAERS
16FatigueFAERS: 2US FAERS
17HeadacheFAERS: 2US FAERS
18Lip swellingFAERS: 2US FAERS
19Medication ErrorFAERS: 2US FAERS
20Metabolic acidosisFAERS: 2US FAERS
21PruritusFAERS: 2US FAERS
22TetanyFAERS: 2US FAERS
23Abdominal PainFAERS: 1US FAERS
24Abdominal discomfortFAERS: 1US FAERS
25Altered state of consciousnessFAERS: 1US FAERS
26Anorectal discomfortFAERS: 1US FAERS
27AnorexiaFAERS: 1US FAERS
28AnoxiaFAERS: 1US FAERS
29AnxietyFAERS: 1US FAERS
30Blood creatinine increasedFAERS: 1US FAERS
31Blood electrolytes decreasedFAERS: 1US FAERS
32Blood glucose increasedFAERS: 1US FAERS
33Blood phosphorus decreasedFAERS: 1US FAERS
34Blood phosphorus increasedFAERS: 1US FAERS
35Blood urea increasedFAERS: 1US FAERS
36BradycardiaFAERS: 1US FAERS
37Cerebrovascular accidentFAERS: 1US FAERS
38Chest PainFAERS: 1US FAERS
39ChillsFAERS: 1US FAERS
40Compression fractureFAERS: 1US FAERS
41DehydrationFAERS: 1US FAERS
42Depressed Level of ConsciousnessFAERS: 1US FAERS
43DisorientationFAERS: 1US FAERS
44Drug dispensing errorFAERS: 1US FAERS
45Drug toxicityFAERS: 1US FAERS
46ErythemaFAERS: 1US FAERS
47Feeling ColdFAERS: 1US FAERS
48General physical health deteriorationFAERS: 1US FAERS
49Head discomfortFAERS: 1US FAERS
50HemiplegiaFAERS: 1US FAERS
51IncontinenceFAERS: 1US FAERS
52Incorrect dose administeredFAERS: 1US FAERS
53InfluenzaFAERS: 1US FAERS
54Infrequent bowel movementsFAERS: 1US FAERS
55LethargyFAERS: 1US FAERS
56Musculoskeletal stiffnessFAERS: 1US FAERS
57MyalgiaFAERS: 1US FAERS
58Optic NeuritisFAERS: 1US FAERS
59Post procedural complicationFAERS: 1US FAERS
60Procedural complicationFAERS: 1US FAERS
61Renal tubular necrosisFAERS: 1US FAERS
62Status EpilepticusFAERS: 1US FAERS
63SwellingFAERS: 1US FAERS
64Unresponsive to verbal stimuliFAERS: 1US FAERS
65Vulvovaginal mycotic infectionFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120237

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.